Affinity Biotech
This article was originally published in The Tan Sheet
Executive Summary
Patent & Trademark Office allows patents covering "neomorphic ibuprofen compositions and methods for their preparation" that "may result in less gastrointestinal irritation than currently marketed forms and cause no burning taste sensation to the user," the Aston, Penn.-based firm said Dec. 17. The new form can be taken as a liquid suspension, a chewable tablet, and as a nonchewable tablet/caplet form.